DE68923882T2 - Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen. - Google Patents

Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen.

Info

Publication number
DE68923882T2
DE68923882T2 DE68923882T DE68923882T DE68923882T2 DE 68923882 T2 DE68923882 T2 DE 68923882T2 DE 68923882 T DE68923882 T DE 68923882T DE 68923882 T DE68923882 T DE 68923882T DE 68923882 T2 DE68923882 T2 DE 68923882T2
Authority
DE
Germany
Prior art keywords
pylori
campylobakter
campylobact
molecular
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68923882T
Other languages
English (en)
Other versions
DE68923882D1 (de
Inventor
Dolores Evans
Doyle Evans
David Graham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Original Assignee
Baylor College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College of Medicine filed Critical Baylor College of Medicine
Application granted granted Critical
Publication of DE68923882D1 publication Critical patent/DE68923882D1/de
Publication of DE68923882T2 publication Critical patent/DE68923882T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
DE68923882T 1988-03-10 1989-03-09 Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen. Expired - Fee Related DE68923882T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/166,138 US4882271A (en) 1988-03-10 1988-03-10 Process for preparation of high molecular weight cell-associated protein of campylobacter pylori and use for serological detection of campylobacter pylori infection
PCT/US1989/000941 WO1989008843A1 (en) 1988-03-10 1989-03-09 Process for preparation of high molecular weight cell-associated protein of campylobacter pylori and use for serological detection of campylobacter pylori infection

Publications (2)

Publication Number Publication Date
DE68923882D1 DE68923882D1 (de) 1995-09-21
DE68923882T2 true DE68923882T2 (de) 1996-03-14

Family

ID=22601983

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68923882T Expired - Fee Related DE68923882T2 (de) 1988-03-10 1989-03-09 Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen.

Country Status (8)

Country Link
US (1) US4882271A (de)
EP (1) EP0439462B1 (de)
JP (1) JP2901296B2 (de)
AT (1) ATE126594T1 (de)
AU (1) AU614608B2 (de)
CA (1) CA1339068C (de)
DE (1) DE68923882T2 (de)
WO (1) WO1989008843A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459041A (en) * 1988-02-18 1995-10-17 Enteric Research Laboratories, Inc. Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection
FR2637612B1 (fr) * 1988-10-06 1993-09-10 Pasteur Institut Sequences de nucleotides codant pour une proteine a activite ureasique
US5234910A (en) * 1989-07-18 1993-08-10 University Hospital Acid inhibitor of bacterial origin
US5200344A (en) * 1990-11-13 1993-04-06 Blaser Martin J Diagnostic testing for campylobacter jejuni or campylobacter coli infections using novel antigens
DE4139840B4 (de) * 1990-12-04 2005-06-02 Quidel Corp., San Diego Antigen-Zubereitung zum Nachweis von H. pylori
US5262156A (en) * 1991-08-12 1993-11-16 Hycor Biomedical, Inc. Antigenic compositions and their use for the detection of Helicobacter pylori
WO1993016723A1 (en) * 1992-02-26 1993-09-02 Vanderbilt University Purified vacuolating toxin from helicobacter pylori and methods to use same
US5859219A (en) * 1992-02-26 1999-01-12 Vanderbilt University Purified vacuolating toxin from Helicobacter pylori and methods to use same
US7141244B1 (en) 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
US6130059A (en) * 1992-03-02 2000-10-10 Covacci; Antonello Helicobacter pylori proteins useful for vaccines and diagnostics
CA2383007A1 (en) * 1992-03-02 1993-09-16 Chiron S.P.A. Helicobacter pylori proteins useful for vaccines and diagnostics
IT1262895B (it) * 1992-03-02 1996-07-22 Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico.
IT1262896B (it) * 1992-03-06 1996-07-22 Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
CA2067603A1 (en) * 1992-04-29 1993-10-30 Auspharm International Ltd. Rapid in vitro test for helicobacter pylori using saliva
PL172125B1 (pl) * 1992-04-29 1997-08-29 Auspharm Int Ltd Sposób wykrywania trwajacych infekcji Helicobacter pyroli w komórkach ssaków PL PL PL
US5420014A (en) * 1992-04-30 1995-05-30 Auspharm International Ltd. Rapid in vitro test for helicobacter pylori using saliva
DE4220653A1 (de) * 1992-06-26 1994-01-13 Boehringer Mannheim Gmbh Verfahren und Mittel zum Nachweis eines Analyten enthaltend glykosidische Tenside
GB9313437D0 (en) * 1993-06-30 1993-08-11 Smith Andrew W Pathogenicity sequences in helicobacter pylori
AU7482694A (en) * 1993-08-27 1995-03-21 Enteric Research Laboratories, Inc. (campylobacter jejuni) antigens, and methods for their production and use
US5780040A (en) * 1994-06-08 1998-07-14 Tufts University School Of Medicine Hospital, Inc. Helicobacter pylori nickel binding protein
GB2290866B (en) * 1994-06-29 1998-10-07 Reckitt & Colmann Prod Ltd Detection of Helicobacter pylori infection using antibodies to carbonic anhydrase
CA2194236C (en) * 1994-07-01 2009-02-24 Dermot Kelleher Helicobacter proteins and vaccines
US6086893A (en) * 1995-10-09 2000-07-11 Pasteur Merieux Serums & Vaccins Helicobacter lactoferrin receptor
DK0909323T3 (da) * 1996-01-04 2007-05-21 Novartis Vaccines & Diagnostic Helicobacter pylori-bakterioferritin
US5932430A (en) * 1996-05-09 1999-08-03 Meridian Diagnostics, Inc. Immunoassay for H. pylori in fecal specimens
US5716791A (en) 1996-05-09 1998-02-10 Meridian Diagnostics, Inc. Immunoassay for H. pylori in fecal specimens
US5942409A (en) * 1998-07-31 1999-08-24 Byk Gulden Lomberg Chemische Fabrik Gmbh Process for identification of substances modulating ureI dependent mechanisms of Helicobacter pylori metabolism
EP1423142A1 (de) * 2001-08-31 2004-06-02 Chiron SRL. Helicobacter pylori impfung mit einer kombination der proteine caga, vaca und nap

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0078152B1 (de) * 1981-10-22 1986-05-07 Tanabe Seiyaku Co., Ltd. Salze der Sulfodehydroabietsäure und Behandlung von gastro-intestinalen Krankheiten
US4579827A (en) * 1983-03-11 1986-04-01 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies
US4785086A (en) * 1985-01-17 1988-11-15 Integrated Genetics, Inc. Test for Campylobacter
CA1274757A (en) * 1985-05-17 1990-10-02 Barry James Marshall Compositions and methods for the detection of urease for the diagnosis of campylobacter pyloridis infection
US4748113A (en) * 1985-06-13 1988-05-31 Marshall Barry J Compositions and methods for the diagnosis of gastrointestinal disorders involving urease
EP0233261A1 (de) * 1985-08-16 1987-08-26 WINN, Gregory, Murray Monoklonale antikörper, reaktiv gegen campylobacter pylorides

Also Published As

Publication number Publication date
JP2901296B2 (ja) 1999-06-07
JPH03504412A (ja) 1991-09-26
US4882271A (en) 1989-11-21
AU3427289A (en) 1989-10-05
AU614608B2 (en) 1991-09-05
ATE126594T1 (de) 1995-09-15
WO1989008843A1 (en) 1989-09-21
CA1339068C (en) 1997-07-29
EP0439462A1 (de) 1991-08-07
EP0439462A4 (de) 1991-06-10
DE68923882D1 (de) 1995-09-21
EP0439462B1 (de) 1995-08-16

Similar Documents

Publication Publication Date Title
DE68923882T2 (de) Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen.
FI870447A (fi) Htlv-iii-hoeljepeptider.
ATE114672T1 (de) Peptidzusammensetzung und verfahren zum nachweis von antikörpern gegen htlv-iii.
ATE141286T1 (de) Hiv-peptide, künstliche hiv-antigene und immuntestsätze
ATE179184T1 (de) Synthetische peptide, spezifisch zum nachweis von gegen hcv gerichteten antikörpern zur diagnose der hcv-infektion und zum vorkommen davon als impfstoffe
ES2082777T3 (es) Un metodo para la deteccion de un anti-cuerpo y antigeno en un inmunoensayo.
DE69126248D1 (de) Immunchromatographischer assay und verfahren zur nutzung desselben
KR890702038A (ko) 인간 혈청에서의 hiv 항원 검출용 효소 면역 분석법
ATE149522T1 (de) Synthetische antigene zum nachweis von antikörpern gegen hepatitis c-virus
ATE140540T1 (de) Verfahren zur zurichtung eines verbesserten western-blott-immuntestverfahrens
DE68925899T2 (de) Bindung von immunkomplexen durch modifizierte formen von c-reaktiven proteinen
UA39944C2 (uk) Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
NO881151L (no) Syntetisk hiv-1-antigen.
ATE2699T1 (de) Serologisches verfahren zum nachweis von neisseria gonorrhoeae antikoerpern im menschlichen serum, ein dazu angewendetes speziesspezifisches waermestabiles antigen und verfahren zur herstellung dieses antigens.
KR880014376A (ko) Hiv 특이 항원 영역의 모노클로날 항체 및 그 용법
DE3579856D1 (de) Immunulogischer test zur bestimmung von gemeinsamen, bestimmenden hepatitis-b-antikoerpern.
DE69026875D1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
DE3686717T2 (de) Immuntestverfahren.
NO852058L (no) Fremgangsmaate og middel for bestemmelse av atl virus antistoffer.
KR910007962A (ko) Hiv 관련 펩티드
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method
ATE114818T1 (de) Immuntest zum nachweis von alpha-haloacetamiden.
SE8901566D0 (sv) Nya peptider inkluderande en disulfidbindning

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee